Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Atherosclerosis
Research
AstraZeneca drug once tested for cancer slows atherosclerosis
Saracatinib reduced signs of atherosclerosis in mice, rabbits and human plasma and tissue samples.
Helen Floersh
Jun 9, 2023 7:40am
Bitterroot Bio emerges from stealth with $145M series A
Jun 7, 2023 8:00am
Scientists pinpoint location of plaque ruptures
Jun 6, 2023 7:35am
Abbott to acquire Cardiovascular Systems for $890M
Feb 9, 2023 10:45am
Shockwave Medical offers $100M for angina device maker Neovasc
Jan 17, 2023 12:18pm
Novo Nordisk taps Microsoft AI to boost drug discovery
Sep 12, 2022 10:32am